Covadonga Pañeda
Directeur des opérations chez ALTAMIRA THERAPEUTICS LTD.
Postes actifs de Covadonga Pañeda
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Directeur des opérations | 01/01/2023 | - |
| Corporate Officer/Principal | - | 01/01/2023 |
Historique de carrière de Covadonga Pañeda
Anciens postes connus de Covadonga Pañeda
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Corporate Officer/Principal | 01/10/2020 | 01/04/2022 |
Sylentis SA
 Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Directeur Technique/Scientifique/R&D | 01/03/2011 | 01/06/2018 |
Formation de Covadonga Pañeda
| Universidad Autónoma de Madrid | Doctorate Degree |
Statistiques
Internationale
| Espagne | 3 |
| Bermudes | 2 |
| France | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Sylentis SA develops new ophthalmic drugs and novel therapies based on RNAi (gene silencig) technology. The company is headquartered in Madrid, Spain. | Health Technology |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Finance |
- Bourse
- Insiders
- Covadonga Pañeda
- Expérience
